Propranolol treatment of paruresis (psychogenic urinary retention): a brief case report.
Propranolol, a nonselective beta-blocker, was administered to a client with paruresis (psychogenic urinary retention) following a novel in vivo exposure treatment. The client did not report a significant increase in his ability to urinate in public facilities during subsequent exposures. Rationale for including propranolol as an adjunct to exposure therapy of paruresis is discussed.
Zgourides
G D
GD
Department of Psychology, University of Portland, Oregon 97203.
Warren
R
R
D000328:Adult; D001143:Arousal / Q000187:drug effects*; D003131:Combined Modality Therapy; D003887:Desensitization, Psychologic / Q000379:methods*; D006801:Humans; D008297:Male; D011433:Propranolol / Q000627:therapeutic use*; D012931:Social Environment; D016055:Urinary Retention / Q000188:drug therapy* / Q000523:psychology
D011433:Propranolol